impact factor
logo
 

Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.

Annual Supplements

In addition to regular issues, it also publishes a number of annual supplements dedicated to the following topics:

Starting in 2022 a new annual issue on Myositis will be published. This monothematic issue will also be the official organ of the International Myositis Society (iMyoS, https://imyos.org).

Articles submitted on these topics are processed with the same peer-review criteria as those published in the regular issues. Once accepted, they are published ahead-of-print online, and subsequently included in the correspondent supplement issue, unless otherwise expressly requested by the Authors.

Articles published in the supplements share the same citation coverage and impact factor as the main journal (PubMed, Scopus, Science Citation Index, etc.).

Editor-in-Chief
Stefano Bombardieri, MD

LER & CER: Letter to the Editor Rheumatology

Letter to Editor Rheumatology: Commentaries and Controversies (LER) has been an online forum for a stronger voice and a wider audience for critical and dissenting views in rheumatology and related disciplines. It has joined forces with Clinical and Experimental Rheumatology to achieve the deserved wider audience.

Letters can be submitted solely to: https://www.clinexprheumatol.org, please read Authors’ Guidelines.

Page charge

A page charge of €100.00 will be assessed for all articles published. Instructions for payment will be sent to authors along with the proofs. There is no charge for solicited articles.

The 5 most viewed PDFs in the last 7 days
in press from 6 month ago (One year in review excluded)

From 09/10/2021 to 16/10/2021

CER15039
Free to view
35 click

Adherence to treatment in Behçet’s syndrome: a multi-faceted issue
S. Pirri, D. Marinello, V. Lorenzoni, G. Andreozzi, A. Bazzani, A. Del Bianco, G. Turchetti, M. Mosca, R. Talarico

Rheumatology Abstract

 

CER14837
Free to view
33 click

Apremilast for oral ulcers associated with active Behçet’s syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial
G. Hatemi, A. Mahr, M. Takeno, D.Y. Kim, D. Saadoun, H. Direskeneli, M. Melikoğlu, S. Cheng, S. Mccue, M. Paris, M. Chen, Y. Yazici

Rheumatology Abstract

 

CER14261
Free to view
29 click

Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial
H.J. Lachmann, B. Lauwerys, P. Miettunen, T. Kallinich, A. Jansson, I. Rosner, R. Manna, S. Murias, S. Savic, S. Smeets, F. De Benedetti, A. Simon

Rheumatology Abstract

 

CER14563
Free to view
29 click

Fibromyalgia position paper
P. Sarzi-Puttini, V. Giorgi, F. Atzeni, R. Gorla, E. Kosek, E.H. Choy, L. Bazzichi, W. Hauser, J.N. Ablin, V. Aloush, D. Buskila, H. Amital, J.A. Da Silva, S. Perrot, B. Morlion, E. Polati, V. Schweiger, S. Coaccioli, G. Varrassi, M. Di Franco, R. Torta,

Rheumatology Abstract

 

CER14985
Free to view
27 click

Flare-up of adult-onset Still’s disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine
S. Yamamoto, K. Nishimura, K. Yo, D. Waki, H. Murabe, T. Yokota

Rheumatology Abstract

 

The 5 most viewed Abstract in the last 7 days
in press from 6 month ago (One year in review excluded)

From 09/10/2021 to 16/10/2021

CER14837
Free to view
26 click

Apremilast for oral ulcers associated with active Behçet’s syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial
G. Hatemi, A. Mahr, M. Takeno, D.Y. Kim, D. Saadoun, H. Direskeneli, M. Melikoğlu, S. Cheng, S. Mccue, M. Paris, M. Chen, Y. Yazici

Rheumatology Abstract

 

CER15039
Free to view
23 click

Adherence to treatment in Behçet’s syndrome: a multi-faceted issue
S. Pirri, D. Marinello, V. Lorenzoni, G. Andreozzi, A. Bazzani, A. Del Bianco, G. Turchetti, M. Mosca, R. Talarico

Rheumatology Abstract

 

CER14767
Free to view
22 click

COVID-19 vaccine hesitancy in systemic sclerosis
J. Ciaffi, D. Giuggioli, A. Mari, M. D'onghia, A. Spinella, V. Brusi, L. Mancarella, L. Lisi, J. Faranda Cordella, D. Freeman, M.P. Landini, C. Ferri, R. Meliconi, F. Ursini

Rheumatology Abstract

 

CER14261
Free to view
19 click

Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial
H.J. Lachmann, B. Lauwerys, P. Miettunen, T. Kallinich, A. Jansson, I. Rosner, R. Manna, S. Murias, S. Savic, S. Smeets, F. De Benedetti, A. Simon

Rheumatology Abstract

 

CER14563
Free to view
17 click

Fibromyalgia position paper
P. Sarzi-Puttini, V. Giorgi, F. Atzeni, R. Gorla, E. Kosek, E.H. Choy, L. Bazzichi, W. Hauser, J.N. Ablin, V. Aloush, D. Buskila, H. Amital, J.A. Da Silva, S. Perrot, B. Morlion, E. Polati, V. Schweiger, S. Coaccioli, G. Varrassi, M. Di Franco, R. Torta,

Rheumatology Abstract

 

CER14985
Free to view
17 click

Flare-up of adult-onset Still’s disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine
S. Yamamoto, K. Nishimura, K. Yo, D. Waki, H. Murabe, T. Yokota

Rheumatology Abstract